COVID-19 Spike Protein Induced Phononic Modification in Antibody-Coupled Graphene for Viral Detection Application

Ngoc Hoang Lan Nguyen1, Sungjoon Kim1, Garrett Lindemann2

  • 1Department of Chemical Engineering, University of Illinois at Chicago, 929 W. Taylor Street, Chicago, Illinois 60607, United States.

ACS Nano
|June 15, 2021
PubMed

Insights

A novel graphene biosensor detects SARS-CoV-2 spike protein with high sensitivity. This rapid diagnostic tool offers potential for early COVID-19 detection and monitoring across variants.

Area of Science:

  • Nanotechnology
  • Biosensing
  • Virology

Background:

  • Early diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for controlling the spread of coronavirus disease 2019 (COVID-19).
  • Existing diagnostic methods can have limitations in terms of speed, sensitivity, or scope.
  • The need for rapid, sensitive, and specific detection of SARS-CoV-2 antigens remains high.

Purpose of the Study:

  • To develop a highly sensitive and selective graphene-based biosensor for detecting SARS-CoV-2 spike protein.
  • To investigate the modification of graphene's dopant density and phononic energy upon interaction with the target analyte.
  • To establish an optical platform for rapid biodetection applicable to various viral strains.

Main Methods:

  • Antibody-coupled graphene was engineered to interface with SARS-CoV-2 spike protein.
  • Changes in graphene's dopant density and phononic energy were monitored as the detection mechanism.
  • The system's performance was evaluated using artificial saliva and phosphate-buffered saline (PBS).

Main Results:

  • The graphene chemeo-phononic system achieved a limit of detection of approximately 3.75 fg/mL in artificial saliva and 1 fg/mL in PBS.
  • The biosensor demonstrated selectivity, distinguishing SARS-CoV-2 spike protein from other proteins in saliva and MERS-CoV spike protein.
  • The detection relies on monitoring changes in graphene phononics, not the analyte's signature.

Conclusions:

  • The developed graphene biosensor offers a highly sensitive and selective method for detecting SARS-CoV-2 spike protein.
  • This optical platform's design allows for adaptability to detect other COVID-19 variants and various specific-binding targets.
  • The technology holds promise for rapid, point-of-care diagnostics and broader biodetection applications.